Skip to main content

Proteome Sciences Wins $850K to ID Biomarkers for Monitoring Effects of Environmental Pollutants


Proteome Sciences said this week it has received a £530,058 ($848,993) grant from the European Union's Framework Seven program for work on the £6.99 million DENAMIC (Developmental Neurotoxicity Assessment of Mixtures in Children) research project, which aims to develop tools for monitoring the neurotoxic effects of environmental pollutants on the cognitive skills and development of children.

Over the next two years the company will investigate the effects of neurotoxic chemicals on proteins, peptides, and biochemical pathways in cell models and tissue to build a database of protein biomarkers linked to various types of chemical exposure.

It plans to use its tandem mass tagging, or TMT, technology combined with mass spectrometry to develop the biomarker assays.

The grant follows on Proteome Sciences' participation in the EU Framework Six Sens-it-iv research project, for which the company did proteomic work investigating in vitro alternatives to animal tests currently used to assess potential skin and lung allergic reactions (PM 05/15/2008).

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.